Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$148M |
| 2 |
Mondelez International
MDLZ
|
+$144M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$53.4M |
| 5 |
Microsoft
MSFT
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$225M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$151M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$91.6M |
| 4 |
Walmart Inc
WMT
|
+$87.7M |
| 5 |
JPMorgan Chase
JPM
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.71% |
| 2 | Healthcare | 20.65% |
| 3 | Consumer Discretionary | 10.85% |
| 4 | Financials | 7.63% |
| 5 | Technology | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Gen Digital
GEN
$17.5B
| $2.37M | 0.01% |
117,882
+35,879
| +44% | +$830K |
|
527
Western Union
WU
$2.21B
| $2.34M | 0.01% |
173,285
+64,093
| +59% | +$1M |
|
528
Federated Hermes
FHI
$4.72B
| $2.34M | 0.01% |
70,544
+22,349
| +46% | +$763K |
|
529
Regency Centers
REG
$14.1B
| $2.33M | 0.01% |
43,218
+125
| +0.3% | +$7.64K |
|
530
Texas Instruments
TXN
$261B
| $2.32M | 0.01% |
14,972
-28,271
| -65% | -$4.74M |
|
531
Amgen
AMGN
$222B
| $2.31M | 0.01% |
10,244
-44,542
| -81% | -$10.8M |
|
532
Brink's
BCO
$4.62B
| $2.31M | 0.01% |
47,652
-10,405
| -18% | -$579K |
|
533
East-West Bancorp
EWBC
$18B
| $2.31M | 0.01% |
34,367
+22,999
| +202% | +$1.64M |
|
|
SBNY
534
DELISTED
Signature Bank
SBNY
| $2.3M | 0.01% |
15,216
+10,121
| +199% | +$1.84M |
|
535
Equinix
EQIX
$103B
| $2.29M | 0.01% |
4,018
-1,662
| -29% | -$1.09M |
|
536
Clearway Energy Class C
CWEN
$6.7B
| $2.28M | 0.01% |
71,688
-12,618
| -15% | -$465K |
|
537
Pediatrix Medical
MD
$2.2B
| $2.26M | 0.01% |
137,131
-117,084
| -46% | -$2.36M |
|
538
3M
MMM
$94.3B
| $2.26M | 0.01% |
24,447
-33,816
| -58% | -$3.71M |
|
|
PPL
539
PPL Corp
PPL
$26.7B
| $2.25M | 0.01% |
88,565
-44,337
| -33% | -$1.27M |
|
540
Snowflake
SNOW
$115B
| $2.22M | 0.01% |
13,079
-8,209
| -39% | -$1.36M |
|
541
RLX Technology
RLX
$2.46B
| $2.22M | 0.01% |
2,116,399
+112,262
| +6% | +$172K |
|
542
Seaboard Corp
SEB
$4.06B
| $2.22M | 0.01% |
653
| – | – |
|
543
SiriusXM
SIRI
$10.1B
| $2.21M | 0.01% |
38,641
-21,961
| -36% | -$1.38M |
|
544
CenterPoint Energy
CNP
$26.8B
| $2.2M | 0.01% |
77,968
+1,068
| +1% | +$33.3K |
|
545
Travelers Companies
TRV
$80.2B
| $2.16M | 0.01% |
14,127
-128,837
| -90% | -$20.9M |
|
546
Bloomin' Brands
BLMN
$938M
| $2.16M | 0.01% |
117,906
-97,934
| -45% | -$1.95M |
|
547
Simulations Plus
SLP
$371M
| $2.15M | 0.01% |
44,362
+30,795
| +227% | +$1.8M |
|
|
VIVO
548
DELISTED
Meridian Bioscience Inc
VIVO
| $2.15M | 0.01% |
68,149
-278
| -0.4% | -$9K |
|
549
Navient
NAVI
$853M
| $2.15M | 0.01% |
+145,999
| New | +$2.23M |
|
550
American Well
AMWL
$230M
| $2.14M | 0.01% |
29,837
+3,092
| +12% | +$271K |
|
Similar funds
Ray Dalio's Q3 2022 Portfolio in Review
As of Q3 2022, Ray Dalio held 1,045 positions worth $19.8B, down 16% from $23.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $2.53B in Q3 2022, closing 179 positions and reducing 498 holdings. Its most notable exit was Medtronic, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ray Dalio opened a new position in Accenture worth $29.3M.
- Ray Dalio's largest Q3 2022 buy was Accenture: 113,811 shares worth $29.3M.
- Ray Dalio added most to Visa in Q3 2022, an estimated $148M increase.
- Ray Dalio's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $151M.
- Ray Dalio fully exited Medtronic in Q3 2022, selling an estimated $225M.
- Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q3 2022.
- Ray Dalio opened 60 new positions and closed 179 in Q3 2022.
- Ray Dalio's portfolio value fell 16% quarter-over-quarter to $19.8B.
Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.